Clinical Trial Update: Michelangelo - Oasis 5 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial for thromboembolism conducted by GlaxoSmithKline has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thromboembolism

Snippet

Sponsor: GlaxoSmithKline | Conditions: Thromboembolism | Phase 3 | Status: COMPLETED